Clipping of news on Brazilian Culture, Law and Citizenship
25/03/2015
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
ANVISA ordered the suspension of the distribution, sale and use of all lots manufactured between August 6 and 31 October 2014 Arcalion medicine (sulbutiamina) 200 mg, indicated for treatments against loss or impairment of physical strength.
The drug, manufactured by Servier Laboratories company in Brazil Ltda, got out of specification results during accelerated stability study.
The measure is in Resolution No. 894, published in the Official Gazette on Tuesday (24/3).
Suspended Cosmetics
ANVISA also ordered the suspension of the distribution, sale and use of all constituents cosmetics Lot 031 856 Amend the Supreme Liss System Kit For Brush Progressive.
The kit consists of Shampoo Deep Cleansing Mask for Shield Smooth Effect and Reducing Emulsion volume. As the emulsion can be sold separately, the Agency also ordered the suspension of the distribution, marketing and use of batch 031,509 this product.
Report issued by the National Institute of Quality Control in Health (INCQS) showed unsatisfactory results in the labeling of testing of the products that make up the kit.
In the analysis of the emulsion was identified unsatisfactory result in the assay for the determination of pH.
The company manufacturer Wellness Industry, Trade and Cosmetic Import Ltda should promote the collection of units that are still available.
The measure is in Resolution No. 892, published in this Tuesday in the Official Gazette.
Source: ANVISA
To access the ANVISA site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typos. transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.